IMO The problem with the change in strategy and focus on FTO meant AML has been overshadowed and we effectively went from a late phase 2 company back to preclinical. SP held up pretty well over last 12mths considering that, but at the present there are too many other events going on affecting the whole markets to keep holding it up. There is still a lot of positives to look forward to, maybe too many to keep track ok, I don't doubt the drug or the company, but the current world climate is a mess, and most are suffering because of it.
RAC - Charts & Price Action, page-10985
-
- There are more pages in this discussion • 10,610 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.89 |
Change
-0.055(2.84%) |
Mkt cap ! $313.4M | |||
| Open | High | Low | Value | Volume |
| $1.95 | $1.95 | $1.84 | $586.7K | 312.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 9407 | $1.87 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.89 | 2667 | 1 |
View Market Depth
| Last trade - 14.27pm 15/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |